Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs.

Szabo A, Gogolak P, Pazmandi K, Kis-Toth K, Riedl K, Wizel B, Lingnau K, Bacsi A, Rethi B, Rajnavolgyi E.

PLoS One. 2013;8(2):e55264. doi: 10.1371/journal.pone.0055264. Epub 2013 Feb 6. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/322893f7-942c-4059-9295-7ecd26162aca.

2.

A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.

Pattacini L, Mize GJ, Graham JB, Fluharty TR, Graham TM, Lingnau K, Wizel B, Perdiguero B, Esteban M, Pantaleo G, Shen M, Spies GA, McElrath MJ, Lund JM.

PLoS One. 2012;7(7):e42163. doi: 10.1371/journal.pone.0042163. Epub 2012 Jul 25.

3.

Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.

Wizel B, Persson J, Thörn K, Nagy E, Harandi AM.

Vaccine. 2012 Jun 19;30(29):4361-8. doi: 10.1016/j.vaccine.2012.02.019.

PMID:
22682292
4.

Effect of age and vaccination on extent and spread of Chlamydia pneumoniae infection in C57BL/6 mice.

Eddens T, Beaudoin S, Steinberger A, Little CS, Shell D, Wizel B, Balin B, Fresa-Dillon KL.

Immun Ageing. 2012 May 17;9(1):11. doi: 10.1186/1742-4933-9-11.

5.

Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis.

Poljak A, Comstedt P, Hanner M, Schüler W, Meinke A, Wizel B, Lundberg U.

Vaccine. 2012 Jun 19;30(29):4398-406. doi: 10.1016/j.vaccine.2011.10.073. Epub 2011 Nov 18.

PMID:
22100635
6.

Induction of protection in mice against a respiratory challenge by a vaccine formulated with the Chlamydia major outer membrane protein adjuvanted with IC31®.

Cheng C, Cruz-Fisher MI, Tifrea D, Pal S, Wizel B, de la Maza LM.

Vaccine. 2011 Mar 16;29(13):2437-43. doi: 10.1016/j.vaccine.2011.01.031. Epub 2011 Jan 26.

PMID:
21276442
7.

Role of CD8(+)T cells in the host response to Chlamydia.

Wizel B, Nyström-Asklin J, Cortes C, Tvinnereim A.

Microbes Infect. 2008 Nov-Dec;10(14-15):1420-30. doi: 10.1016/j.micinf.2008.08.006. Epub 2008 Aug 26. Review.

8.

Chlamydia pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab GTPases.

Cortes C, Rzomp KA, Tvinnereim A, Scidmore MA, Wizel B.

Infect Immun. 2007 Dec;75(12):5586-96. Epub 2007 Oct 1.

10.

A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae.

Pinchuk I, Starcher BC, Livingston B, Tvninnereim A, Wu S, Appella E, Sidney J, Sette A, Wizel B.

J Immunol. 2005 May 1;174(9):5729-39.

11.

Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles.

Shams H, Klucar P, Weis SE, Lalvani A, Moonan PK, Safi H, Wizel B, Ewer K, Nepom GT, Lewinsohn DM, Andersen P, Barnes PF.

J Immunol. 2004 Aug 1;173(3):1966-77.

12.

The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo.

Wu S, Howard ST, Lakey DL, Kipnis A, Samten B, Safi H, Gruppo V, Wizel B, Shams H, Basaraba RJ, Orme IM, Barnes PF.

Mol Microbiol. 2004 Mar;51(6):1551-62.

13.

NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.

Vankayalapati R, Klucar P, Wizel B, Weis SE, Samten B, Safi H, Shams H, Barnes PF.

J Immunol. 2004 Jan 1;172(1):130-7.

14.

Human CD8+ T cells recognize epitopes of the 28-kDa hemolysin and the 38-kDa antigen of Mycobacterium tuberculosis.

Shams H, Barnes PF, Weis SE, Klucar P, Wizel B.

J Leukoc Biol. 2003 Dec;74(6):1008-14. Epub 2003 Sep 12.

PMID:
12972510
15.

The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes.

Shams H, Wizel B, Lakey DL, Samten B, Vankayalapati R, Valdivia RH, Kitchens RL, Griffith DE, Barnes PF.

FEMS Immunol Med Microbiol. 2003 May 15;36(1-2):63-9.

16.

CD40 ligand trimer enhances the response of CD8+ T cells to Mycobacterium tuberculosis.

Samten B, Wizel B, Shams H, Weis SE, Klucar P, Wu S, Vankayalapati R, Thomas EK, Okada S, Krensky AM, Barnes PF.

J Immunol. 2003 Mar 15;170(6):3180-6.

17.

Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis.

Vankayalapati R, Wizel B, Weis SE, Klucar P, Shams H, Samten B, Barnes PF.

Clin Infect Dis. 2003 Jan 1;36(1):24-8. Epub 2002 Dec 10.

PMID:
12491197
18.

Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.

Wizel B, Starcher BC, Samten B, Chroneos Z, Barnes PF, Dzuris J, Higashimoto Y, Appella E, Sette A.

J Immunol. 2002 Sep 1;169(5):2524-35.

19.

Reduced expression of nuclear cyclic adenosine 5'-monophosphate response element-binding proteins and IFN-gamma promoter function in disease due to an intracellular pathogen.

Samten B, Ghosh P, Yi AK, Weis SE, Lakey DL, Gonsky R, Pendurthi U, Wizel B, Zhang Y, Zhang M, Gong J, Fernandez M, Safi H, Vankayalapati R, Young HA, Barnes PF.

J Immunol. 2002 Apr 1;168(7):3520-6.

20.

The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium.

Vankayalapati R, Wizel B, Weis SE, Safi H, Lakey DL, Mandelboim O, Samten B, Porgador A, Barnes PF.

J Immunol. 2002 Apr 1;168(7):3451-7.

21.

T cells enhance production of IL-18 by monocytes in response to an intracellular pathogen.

Vankayalapati R, Wizel B, Lakey DL, Zhang Y, Coffee KA, Griffith DE, Barnes PF.

J Immunol. 2001 Jun 1;166(11):6749-53.

22.

Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis.

Shams H, Wizel B, Weis SE, Samten B, Barnes PF.

Infect Immun. 2001 May;69(5):3497-501.

23.

Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex.

Vankayalapati R, Wizel B, Samten B, Griffith DE, Shams H, Galland MR, Von Reyn CF, Girard WM, Wallace RJ Jr, Barnes PF.

J Infect Dis. 2001 Feb 1;183(3):478-84. Epub 2000 Dec 20.

PMID:
11133380
24.

Production of interleukin-18 in human tuberculosis.

Vankayalapati R, Wizel B, Weis SE, Samten B, Girard WM, Barnes PF.

J Infect Dis. 2000 Jul;182(1):234-9. Epub 2000 Jun 29.

PMID:
10882602
25.

Type 1 cytokines and the pathogenesis of tuberculosis.

Barnes PF, Wizel B.

Am J Respir Crit Care Med. 2000 Jun;161(6):1773-4. No abstract available.

PMID:
10852738
26.
28.

Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.

Wizel B, Palmieri M, Mendoza C, Arana B, Sidney J, Sette A, Tarleton R.

J Clin Invest. 1998 Sep 1;102(5):1062-71.

29.

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR, et al.

J Infect Dis. 1998 Jun;177(6):1664-73.

PMID:
9607847
30.
31.

Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL.

Low HP, Santos MA, Wizel B, Tarleton RL.

J Immunol. 1998 Feb 15;160(4):1817-23.

32.

Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes.

Charoenvit Y, Fallarme V, Rogers WO, Sacci JB Jr, Kaur M, Aguiar JC, Yuan LF, Corradin G, Andersen E, Wizel B, Houghten RA, Oloo A, De la Vega P, Hoffman SL.

Infect Immun. 1997 Aug;65(8):3430-7.

33.
34.
35.
36.

HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.

Wizel B, Houghten R, Church P, Tine JA, Lanar DE, Gordon DM, Ballou WR, Sette A, Hoffman SL.

J Immunol. 1995 Jul 15;155(2):766-75.

PMID:
7541824
37.

Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.

Roeffen W, Geeraedts F, Eling W, Beckers P, Wizel B, Kumar N, Lensen T, Sauerwein R.

Infect Immun. 1995 Feb;63(2):467-71. Erratum in: Infect Immun 1995 Aug;63(8):3240.

38.

Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2.

Wizel B, Rogers WO, Houghten RA, Lanar DE, Tine JA, Hoffman SL.

Eur J Immunol. 1994 Jul;24(7):1487-95.

PMID:
7517870
39.

Further characterization of interactions between gamete surface antigens of Plasmodium falciparum.

Kumar N, Wizel B.

Mol Biochem Parasitol. 1992 Jul;53(1-2):113-20.

PMID:
1380124
40.

Supplemental Content

Support Center